Jazz Pharmaceuticals (JAZZ) Net Equity Issued and Repurchased (2010)

Jazz Pharmaceuticals' (JAZZ) quarterly Net Equity Issued and Repurchased came in at -$302000.0 in Q3 2010.

Jazz Pharmaceuticals (JAZZ) Net Equity Issued and Repurchased (2010) Analysis & Trends

Jazz Pharmaceuticals' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$302000.0 for Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	163.10 Mn
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	141.90 Mn
10	Jazz Pharmaceuticals	15.81 Bn	13.96 Bn	934.80 Mn	-

Download Data

Date	Value
Sep 30, 2010	-302,000.00
Sep 30, 2010	-302,000.00